u/injection_site_iris

I am going to push back on this slightly.

The confident tone is doing a lot of work that the evidence is not.

the wiki is the source

Disagree. What you are describing is consistent with special authorization, not with what you concluded.

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

STEP 1 readout: 99.2% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

Yeah, glucagon co-agonism is genuinely different.

Strongly agree. Phase 2 is investigational, not conclusive.

the safety profile is not just tirzepatide amplified

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

give the trial name, phase, n, and primary endpoint in the body

phase 2 is not phase 3, smaller n and shorter trial

sponsor and disclosure questions are always answered publicly

nobody should be giving this to anyone without extensive monitoring

no images, none, not even redacted ones

Slight fix: the number was 99.3, not 93.7. Decimal point, but a fairly consequential one.

the 2.5mg arm is different from 5mg, results do not transfer

Came off after 92 weeks for financial reasons.

Adding to this: discontinuation is doing more work than the comment implies.

retatrutide is not approved anywhere for human use, posts must not read as instructions

Yes, exactly this, and it is the bit that took me 60 weeks to accept.